0000899243-19-001649.txt : 20190122 0000899243-19-001649.hdr.sgml : 20190122 20190122175456 ACCESSION NUMBER: 0000899243-19-001649 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190110 FILED AS OF DATE: 20190122 DATE AS OF CHANGE: 20190122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Welch David F CENTRAL INDEX KEY: 0001399122 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 19536161 MAIL ADDRESS: STREET 1: C/O INFINERA CORPORATION STREET 2: 140 CASPIAN COURT CITY: SUNNYVALE STATE: CA ZIP: 94089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-01-10 0 0001175680 CytoDyn Inc. CYDY 0001399122 Welch David F 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 1 0 0 0 Common Stock 963333 I See Footnote Common Stock 1675280 I See Footnote Warrant (Right to Buy) 0.75 2021-01-28 Common Stock 166666 I See Footnote Warrant (Right to Buy) 0.75 2023-02-16 Common Stock 600000 I See Footnote Warrant (Right to Buy) 0.30 2023-12-28 Common Stock 1000000 I See Footnote Warrant (Right to Buy) 0.75 2022-09-08 Common Stock 384615 I See Footnote Warrant (Right to Buy) 0.75 2023-09-14 Common Stock 500000 I See Footnote Convertible Promissory Note 0.50 2019-09-28 Common Stock 2000000 I See Footnote The securities were exercisable on the date of the event which required the filing of this report. The reported securities of CytoDyn Inc. (the "Company") are held by LRFA, LLC, a Delaware limited liability company ("LRFA"). David F. Welch, Ph.D. is the sole managing member of LRFA. Dr. Welch disclaims beneficial ownership of the securities held by LRFA, except to the extent of his pecuniary interest therein. The reported securities of the Company are held by David Welch Tr Ua 03/02/2000 Welch Charitable Remainder Unitrust Agreement II, for which Dr. Welch is a trustee. Does not include additional shares issuable upon conversion of accrued interest. Subject to adjustment in the event of certain stock split or reverse stock split recapitalizations. /s/ Michael D. Mulholland, as attorney-in-fact 2019-01-22